Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Researchers who recently set out to understand the US public’s views on the risks and benefits of marijuana use have found that Americans view the drug more favourably than existing evidence...

Scientists who set out to investigate the associations between dietary patterns and risk of a first clinical diagnosis of central nervous system demyelination, a common precursor to...

Argos, Asda, Barclays, Marks & Spencer and Sainsbury’s are just some of the leading high street retailers to have signed up to...

MS Conference edited.pngThe Prime Minister has recognised...

A phase 1 study of the potential B-cell targeting oral multiple sclerosis (MS) treatment PRN2246 has shown its ability to cross the human blood brain barrier.

The double blind, placebo...

Depending on the course of multiple sclerosis (MS), quality of life can be...

A new drug application for cladribine tablets as a potential treatment for relapsing remitting multiple sclerosis (RRMS) patients has been accepted for consideration by the US Food and Drug...

Pages

Live Chat Software by Click4Assistance UK